Related Experiment Video
Updated: Dec 9, 2025

06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
51.5K
Titinopathy, an atypical respiratory failure
Joana Morais1, Ana Andrade Oliveira2, Olga Pires2
1Internal Medicine, Hospital de Braga, Braga, Portugal joana.morais.vnf@gmail.com.
BMJ Case Reports
|September 11, 2020
Summary
This study details a rare hereditary myopathy causing early respiratory failure. A genetic mutation in the titin gene was identified in a patient with progressive muscle weakness and breathing difficulties.
Area of Science:
- Neurology
- Genetics
- Pulmonology
Background:
- Hereditary myopathy with early respiratory failure (HME-RF) is a rare neuromuscular disorder.
- It follows an autosomal dominant inheritance pattern, presenting with muscle weakness and respiratory issues.
- Currently, no disease-modifying therapies exist for HME-RF, and its prognosis remains uncertain.
Observation:
- A 40-year-old woman presented with chronic fatigue, apathy, and recent onset of daytime sleepiness, dyspnea, and ambulation difficulties.
- Diagnostic workup revealed hypercapnic respiratory failure with severe acidemia.
- Muscle biopsy findings included cytoplasmic bodies and rimmed vacuoles, characteristic of HME-RF.
Findings:
- Genetic analysis identified a heterozygous mutation (c.95134T>C, p.Cys31712Arg) in exon 343 of the titin gene.
- This genetic finding confirmed the diagnosis of hereditary myopathy with early respiratory failure.
- The patient exhibited symptoms consistent with the established clinical presentation of the disease.
Implications:
- This case highlights the importance of genetic testing in diagnosing HME-RF.
- The identification of a titin gene mutation provides further insight into the genetic basis of this myopathy.
- Supportive care, including non-invasive ventilation, is crucial for managing respiratory complications in HME-RF patients.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-III
588
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
588
Acute Respiratory Failure-II
856
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
856
Acute Respiratory Failure-I
625
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
625
Acute Respiratory Failure-V
339
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
339
Acute Respiratory Failure-IV
402
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
402
Pneumothorax-I
887
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
887

